• Publications
  • Influence
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk
OBJECTIVE To determine whether there are any differences in the incidence of ovarian hyperstimulation syndrome (OHSS) and implantation rates in high-risk patients undergoing IVF using a protocolExpand
  • 319
  • 21
Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization.
OBJECTIVE To determine the role of endometrial sampling for identification and treatment of chronic endometritis (CE) in patients undergoing IVF-ET who repeatedly failed to conceive despite theExpand
  • 155
  • 10
Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
OBJECTIVE To compare live birth rates after dual trigger of oocyte maturation with GnRH agonist (GnRHa) and low-dose hCG versus GnRHa alone in high responders with peak E(2) <4,000 pg/mL at risk ofExpand
  • 86
  • 9
The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study.
OBJECTIVE To determine whether the use of luteal phase vaginal E(2) supplementation improves clinical pregnancy rates in patients undergoing IVF treatment. DESIGN Prospective randomized controlledExpand
  • 55
  • 9
The presence of multinucleated blastomeres in human embryos is correlated with chromosomal abnormalities.
The purpose of the present study was to determine whether the presence of one or more multinucleated blastomeres during early embryonic development is associated with chromosomal abnormalities inExpand
  • 170
  • 6
  • PDF
Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome.
OBJECTIVE To evaluate the outcomes of IVF and the incidence of ovarian hyperstimulation syndrome (OHSS) after discontinuing gonadotropin therapy in patients at risk of developing OHSS by delaying hCGExpand
  • 108
  • 6
Optimal usage of the GnRH antagonists: a review of the literature
Gonadotropin-releasing hormone (GnRH) antagonists, which became commercially available from 1999, have been used for the prevention of premature luteinizing hormone (LH) surges in controlled ovarianExpand
  • 34
  • 6
  • PDF
Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
STUDY QUESTION Are there factors predicting the number of total and mature oocytes retrieved after controlled ovarian hyperstimulation (COH) utilizing a gonadotropin-releasing hormone (GnRH)Expand
  • 47
  • 5
  • PDF
A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders.
Forty-eight patients who met the criteria of poor response during prior gonadotropin stimulation were enrolled in a randomized prospective study comparing a gonadotropin-releasing hormone (GnRH)Expand
  • 72
  • 4